Brind.

Entities / Government agency

Swissmedic.

licensing and inspection authority for remedies in Switzerland with headquarters in Bern

Seen in 6 reportsLast reported Oct 13

Reports this week: 0
Active events: 0
Connections: 11

What's happening

One to three months ago

Novartis sought Swissmedic regulatory approval for a drug, which was co-funded by Sida and introduced first in Ghana.

Some support1 report

Gone quiet

No new reports in 90+ days

Swissmedic approved a new malaria medicine from Novartis on July 8, 2025.

Speculative1 report
Mainz Biomed N.V. received regulatory approval from Swissmedic in Switzerland on August 13, 2025, allowing ColoAlert® to be marketed in select European countries.

Some support2 reports

Around Swissmedic this week

News at the entities that move Swissmedic most

Novartis Structural
Bristol-Myers Squibb paused clinical trials following clinical setbacks reported by Novartis.

Moves Swissmedic
14:21
Ghana Mentioned together
Parallex Bank is sending winners to Ghana.

Moves Swissmedic
18:05

Connections

The 2 strongest of 11, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.

Novartis Structural

Novartis relies on Swissmedic for product approval and market access in Switzerland.

Some supportSep 15

Swissmedic → Novartis
Novartis → Swissmedic
Ghana Mentioned together

The evidence places Ghana as the location where a drug was introduced, while Swissmedic is a related regulatory body mentioned in the same context.

Some supportSep 15

Swissmedic → Ghana
Ghana → Swissmedic

History

Events by the month they began

September 2026

1 event

Sep 15, 2026Novartis sought Swissmedic regulatory approval for a drug, which was co-funded by Sida and introduced first in Ghana.

June 2026

2 events